Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: A retrospective analysis of deaths in the United States from 1999-2020.

<h4>Background</h4>Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) greatly influence morbidity and mortality, with COPD patients frequently suffering from cardiovascular comorbidities like coronary heart disease and stroke. This study analyzes mortality tren...

Full description

Saved in:
Bibliographic Details
Main Authors: Aman Goyal, Humza Saeed, Wania Sultan, Ajeet Singh, Abdullah, Muhammad Khubaib Arshad, Zubair Amin, Mah I Kan Changez, Gauranga Mahalwar, Rozi Khan, Wael AlJaroudi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0317592
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823864087435542528
author Aman Goyal
Humza Saeed
Wania Sultan
Ajeet Singh
Abdullah
Muhammad Khubaib Arshad
Zubair Amin
Mah I Kan Changez
Gauranga Mahalwar
Rozi Khan
Wael AlJaroudi
author_facet Aman Goyal
Humza Saeed
Wania Sultan
Ajeet Singh
Abdullah
Muhammad Khubaib Arshad
Zubair Amin
Mah I Kan Changez
Gauranga Mahalwar
Rozi Khan
Wael AlJaroudi
author_sort Aman Goyal
collection DOAJ
description <h4>Background</h4>Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) greatly influence morbidity and mortality, with COPD patients frequently suffering from cardiovascular comorbidities like coronary heart disease and stroke. This study analyzes mortality trends and disparities among individuals in the United States (US) affected by both CVD and COPD.<h4>Methods</h4>This study analyzed death certificates from the CDC WONDER database for individuals aged 25 and older who died between 1999 and 2020 with both CVD (ICD I00-I99) and COPD (ICD J41-J44). Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, sex, age group, race/ethnicity, geographic region, and urbanization status.<h4>Results</h4>Between 1999 and 2020, there were 3,590,124 reported deaths due to coexisting CVD and COPD, with overall AAMR slightly changing from 82.2 to 81.2 per 100,000 population, and a notable rise from 2018 to 2020 (APC: 5.28; 95% CI: 1.83 to 7.22) coinciding with the onset of COVID-19 pandemic. A similar surge in mortality was observed across multiple demographic subgroups, particularly among older adults. Disparities across age groups, sex, race, and geographic location were also observed in the mortality rates due to CVD and COPD. When analyzed by age group, older adults exhibited the highest AAMR at 824.1. Men had higher AAMRs than women (96.5 vs. 60.7). Ethnoracial analysis showed that non-Hispanic (NH) White individuals had the highest AAMRs (82.0), followed by NH American Indian or Alaska Native (74.5), NH Black (63.6), Hispanic (38.1), and NH Asian or Pacific Islander (25.1) individuals. Additionally, non-metropolitan areas had higher AAMRs compared to metropolitan areas (96.2 vs. 70.9).<h4>Conclusions</h4>The findings suggest that mortality rates for CVD and COPD have increased in recent years, coinciding with the onset of the COVID-19 pandemic, which may have exacerbated outcomes in vulnerable populations. The study highlights the need for targeted interventions to address the overlapping impacts of CVD and COPD, especially in high-risk groups.
format Article
id doaj-art-73d1c60cec904bbfbbeacc6e2d162a27
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-73d1c60cec904bbfbbeacc6e2d162a272025-02-09T05:30:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01202e031759210.1371/journal.pone.0317592Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: A retrospective analysis of deaths in the United States from 1999-2020.Aman GoyalHumza SaeedWania SultanAjeet SinghAbdullahMuhammad Khubaib ArshadZubair AminMah I Kan ChangezGauranga MahalwarRozi KhanWael AlJaroudi<h4>Background</h4>Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) greatly influence morbidity and mortality, with COPD patients frequently suffering from cardiovascular comorbidities like coronary heart disease and stroke. This study analyzes mortality trends and disparities among individuals in the United States (US) affected by both CVD and COPD.<h4>Methods</h4>This study analyzed death certificates from the CDC WONDER database for individuals aged 25 and older who died between 1999 and 2020 with both CVD (ICD I00-I99) and COPD (ICD J41-J44). Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, sex, age group, race/ethnicity, geographic region, and urbanization status.<h4>Results</h4>Between 1999 and 2020, there were 3,590,124 reported deaths due to coexisting CVD and COPD, with overall AAMR slightly changing from 82.2 to 81.2 per 100,000 population, and a notable rise from 2018 to 2020 (APC: 5.28; 95% CI: 1.83 to 7.22) coinciding with the onset of COVID-19 pandemic. A similar surge in mortality was observed across multiple demographic subgroups, particularly among older adults. Disparities across age groups, sex, race, and geographic location were also observed in the mortality rates due to CVD and COPD. When analyzed by age group, older adults exhibited the highest AAMR at 824.1. Men had higher AAMRs than women (96.5 vs. 60.7). Ethnoracial analysis showed that non-Hispanic (NH) White individuals had the highest AAMRs (82.0), followed by NH American Indian or Alaska Native (74.5), NH Black (63.6), Hispanic (38.1), and NH Asian or Pacific Islander (25.1) individuals. Additionally, non-metropolitan areas had higher AAMRs compared to metropolitan areas (96.2 vs. 70.9).<h4>Conclusions</h4>The findings suggest that mortality rates for CVD and COPD have increased in recent years, coinciding with the onset of the COVID-19 pandemic, which may have exacerbated outcomes in vulnerable populations. The study highlights the need for targeted interventions to address the overlapping impacts of CVD and COPD, especially in high-risk groups.https://doi.org/10.1371/journal.pone.0317592
spellingShingle Aman Goyal
Humza Saeed
Wania Sultan
Ajeet Singh
Abdullah
Muhammad Khubaib Arshad
Zubair Amin
Mah I Kan Changez
Gauranga Mahalwar
Rozi Khan
Wael AlJaroudi
Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: A retrospective analysis of deaths in the United States from 1999-2020.
PLoS ONE
title Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: A retrospective analysis of deaths in the United States from 1999-2020.
title_full Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: A retrospective analysis of deaths in the United States from 1999-2020.
title_fullStr Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: A retrospective analysis of deaths in the United States from 1999-2020.
title_full_unstemmed Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: A retrospective analysis of deaths in the United States from 1999-2020.
title_short Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: A retrospective analysis of deaths in the United States from 1999-2020.
title_sort mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease a retrospective analysis of deaths in the united states from 1999 2020
url https://doi.org/10.1371/journal.pone.0317592
work_keys_str_mv AT amangoyal mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT humzasaeed mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT waniasultan mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT ajeetsingh mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT abdullah mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT muhammadkhubaibarshad mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT zubairamin mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT mahikanchangez mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT gaurangamahalwar mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT rozikhan mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020
AT waelaljaroudi mortalitytrendsanddisparitiesforcoexistingchronicobstructivepulmonarydiseaseandcardiovasculardiseasearetrospectiveanalysisofdeathsintheunitedstatesfrom19992020